← brief for 2026-09-16 · People & money

Making Modern Diabetes Medications Affordable and Accessible: Lessons From India for Other Countries.

Article No results yet Not peer reviewed

Key takeaways

This article looks at how India lowered the price of newer diabetes drugs, including SGLT2 inhibitors and GLP-1 drugs. These drugs help protect the heart and kidneys, but cost keeps many people from getting them. About 589 million adults have diabetes, and 80% of them live in lower-income countries. This is a policy analysis, not a study of patients, so it has no health results.

Who did this work

Mohan V · Sathweek RS · Anjana RM · Unnikrishnan R

Source

Article · PubMed, the drug frontier · 2026 Sep 16
https://pubmed.ncbi.nlm.nih.gov/42747945/